Your browser doesn't support javascript.
loading
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study.
Capell, Warren H; Barnathan, Elliot S; Piazza, Gregory; Spyropoulos, Alex C; Hsia, Judith; Bull, Scott; Lipardi, Concetta; Sugarmann, Chiara; Suh, Eunyoung; Rao, Jaya Prakash; Hiatt, William R; Bonaca, Marc P.
Affiliation
  • Capell WH; CPC Clinical Research, Aurora, CO; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO. Electronic address: warren.capell@cuanschutz.edu.
  • Barnathan ES; Janssen Research and Development LLC, Raritan, NJ.
  • Piazza G; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Spyropoulos AC; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Huntington, NY; Institute for Health Innovation and Outcomes Research, Feinstein Institutes for Medical Research, Manhasset, NY; Department of Medicine, Northwell Health at Lenox Hill Hospital, New York, NY.
  • Hsia J; CPC Clinical Research, Aurora, CO; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Bull S; Janssen Research and Development LLC, Raritan, NJ.
  • Lipardi C; Janssen Research and Development LLC, Raritan, NJ.
  • Sugarmann C; Janssen Research and Development LLC, Raritan, NJ.
  • Suh E; Janssen Research and Development LLC, Raritan, NJ.
  • Rao JP; REDCap Cloud, Encinitas, CA.
  • Hiatt WR; CPC Clinical Research, Aurora, CO; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Bonaca MP; CPC Clinical Research, Aurora, CO; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
Am Heart J ; 235: 12-23, 2021 05.
Article in En | MEDLINE | ID: mdl-33577800

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Outpatients / Thrombosis / Factor Xa Inhibitors / Rivaroxaban / COVID-19 / Hospitalization Type of study: Clinical_trials / Etiology_studies Language: En Journal: Am Heart J Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Outpatients / Thrombosis / Factor Xa Inhibitors / Rivaroxaban / COVID-19 / Hospitalization Type of study: Clinical_trials / Etiology_studies Language: En Journal: Am Heart J Year: 2021 Type: Article